We propose a model that in PTEN-deficient tumour cells, DAXX removes H3.3 from chromatin (Fig. 6h, Supplementary Fig. 21a), probably by competing for chromatin binding, as has been reported by other groups45. Here, PTEN is linked to neoplasm.